Dr Reddy

Dr. Reddy’s to focus on complex products as growth driver to offset Revlimid revenue loss

2025-01-23 22:13:00 : Dr. Reddy’s is focused on a range of complex drugs, including GLP-1 (such as semaglutide), as well as biosimilars and consumer ...